DEVELOPMENT AND CHARACTERIZATION OF PROTRANSFERSOMES LOADED WITH MODEL DRUG FOR TRANSDERMAL DELIVERY
Repaglinide (REP) is an oral synthetic antidiabetic that is administered to enhance meal-induced insulin production. It is quickly excreted from the body through the biliary system. Due its first-pass metabolism that occurs in the liver, REP has a low oral bioavailability of 56%. Its half-life in sy...
Guardado en:
| Autores principales: | , , , , |
|---|---|
| Formato: | Artigo |
| Lenguaje: | Inglês |
| Publicado: |
Al-Azhar University, Faculty of Pharmacy
2024-09-01
|
| Colección: | Al-Azhar Journal of Pharmaceutical Sciences |
| Materias: | |
| Acceso en línea: | https://ajps.journals.ekb.eg/article_429434_7ee655b0e67a58cfc6d807ed3ef0dd23.pdf |
| Etiquetas: |
Sin Etiquetas, Sea el primero en etiquetar este registro!
|